Reminyl Name Change Gives J&J Fresh Message For Galantamine ER Launch
Executive Summary
Janssen's name change for its Reminyl Alzheimer's products gives the company a fresh platform for promoting the galantamine extended-release formulation approved by FDA Dec. 22
You may also be interested in...
Reminyl name change no remedy
Pharmacists are reporting confusion between Takeda's sleep aid Rozerem (ramelteon) and J&J's Alzheimer's therapy Razadyne (galantamine), according to the Institute for Safe Medication Practice's Medication Safety Alert. Name confusion is not a new problem for the J&J product; formerly Reminyl, the company renamed galantamine Razadyne in 2005 due to confusion with Sanofi-Aventis' anti-diabetic Amaryl (glimepiride) (1"The Pink Sheet" Jan. 10, 2005, p. 8)...
Reminyl name change no remedy
Pharmacists are reporting confusion between Takeda's sleep aid Rozerem (ramelteon) and J&J's Alzheimer's therapy Razadyne (galantamine), according to the Institute for Safe Medication Practice's Medication Safety Alert. Name confusion is not a new problem for the J&J product; formerly Reminyl, the company renamed galantamine Razadyne in 2005 due to confusion with Sanofi-Aventis' anti-diabetic Amaryl (glimepiride) (1"The Pink Sheet" Jan. 10, 2005, p. 8)...
Ortho McNeil Neurologics To Promote Razadyne (Formerly Reminyl)
Johnson & Johnson is changing the name of Reminyl (galantamine) to Razadyne in advance of the launch of an extended-release version of the Alzheimer's product